Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Bestagno

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
BMC Biotechnology|August 7, 2007
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal modelsRoberto Di Niro, Federica Ziller, Fiorella Florian, et al.
Oncotarget|August 24, 2015
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killingMalvina Prapa, Sara Caldrer, Carlotta Spano, et al.
Cell Reports|April 12, 2024
Tim4 enables large peritoneal macrophages to cross-present tumor antigens at early stages of tumorigenesisSonal Joshi, Lucía López, Luciano Gastón Morosi, et al.
Cancer Gene Therapy|November 23, 2018
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitorsGiulia Golinelli, Giulia Grisendi, Malvina Prapa, et al.
Plant Biotechnology Journal|February 21, 2007
An antibody derivative expressed from viral vectors passively immunizes pigs against transmissible gastroenteritis virus infection when supplied orally in crude plant extractsWendy Monger, Josefa M Alamillo, Isabel Sola, et al.
Biotechnology Journal|September 28, 2006
Use of virus vectors for the expression in plants of active full-length and single chain anti-coronavirus antibodiesJosefa M Alamillo, Wendy Monger, Isabel Sola, et al.
Oncotarget|April 11, 2015
Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cellsMoitza Principe, Patrizia Ceruti, Neng-Yao Shih, et al.
NPJ Precision Oncology|October 28, 2021
GD2 CAR T cells against human glioblastomaMalvina Prapa, Chiara Chiavelli, Giulia Golinelli, et al.
Theranostics|February 28, 2019
MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic AdenocarcinomaFilippo Rossignoli, Carlotta Spano, Giulia Grisendi, et al.
Scientific Reports|February 12, 2019
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic CancerCarlotta Spano, Giulia Grisendi, Giulia Golinelli, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
BMC Biotechnology|August 7, 2007
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal modelsRoberto Di Niro, Federica Ziller, Fiorella Florian, et al.
Oncotarget|August 24, 2015
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killingMalvina Prapa, Sara Caldrer, Carlotta Spano, et al.
Cell Reports|April 12, 2024
Tim4 enables large peritoneal macrophages to cross-present tumor antigens at early stages of tumorigenesisSonal Joshi, Lucía López, Luciano Gastón Morosi, et al.
Cancer Gene Therapy|November 23, 2018
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitorsGiulia Golinelli, Giulia Grisendi, Malvina Prapa, et al.
Plant Biotechnology Journal|February 21, 2007
An antibody derivative expressed from viral vectors passively immunizes pigs against transmissible gastroenteritis virus infection when supplied orally in crude plant extractsWendy Monger, Josefa M Alamillo, Isabel Sola, et al.
Biotechnology Journal|September 28, 2006
Use of virus vectors for the expression in plants of active full-length and single chain anti-coronavirus antibodiesJosefa M Alamillo, Wendy Monger, Isabel Sola, et al.
Oncotarget|April 11, 2015
Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cellsMoitza Principe, Patrizia Ceruti, Neng-Yao Shih, et al.
NPJ Precision Oncology|October 28, 2021
GD2 CAR T cells against human glioblastomaMalvina Prapa, Chiara Chiavelli, Giulia Golinelli, et al.
Theranostics|February 28, 2019
MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic AdenocarcinomaFilippo Rossignoli, Carlotta Spano, Giulia Grisendi, et al.
Scientific Reports|February 12, 2019
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic CancerCarlotta Spano, Giulia Grisendi, Giulia Golinelli, et al.
Pageof 4